In this study, we have utilized the triple-negative MDA-MB-231 breast cancer line and selective short hairpin RNA (shRNA) knockdown strategy to assess the cellular function under the control of ERK5 that influences the course of breast tumor progression and metastasis. This evidence concerns the gene MAPK7 and breast neoplasm.